---
figid: PMC6438456__pcbi.1006658.g010
figtitle: 'Review: Precision medicine and driver mutations: Computational methods,
  functional assays and conformational principles for interpreting cancer drivers'
organisms:
- NA
pmcid: PMC6438456
filename: pcbi.1006658.g010.jpg
figlink: /pmc/articles/PMC6438456/figure/pcbi.1006658.g010/
number: F10
caption: Representatives shown for the MAPK, PI3K/Akt, and Wnt pathways. In the MAPK
  pathway, Ras gets activated in the presence of the EGFR signal and forms nanoclusters
  that promote Raf dimerization. Autophosphorylated, active Raf dimer phosphorylates
  and activatesMEK 1/2, and subsequently phosphorylates and activates ERK 1/2, leading
  to cell proliferation. In the PI3K/Akt pathway, both Ras and RTK activate PI3K,
  recruiting it to the plasma membrane, where PI3K phosphorylates PIP2 to produce
  PIP3. The tumor suppressor PTEN can reverse the PIP3 production. PIP3 recruits both
  PDK and Akt to the plasma membrane, where PDK and mTORC2 activate Akt, and active
  Akt phosphorylates the mTORC1, leading to cell growth. The canonical Wnt pathway
  involves an accumulation of β-catenin in the cytoplasm and translocates β-catenin
  to the nucleus where it binds to TCF/LEF transcription factors. β-catenin upregulates
  c-Myc. In the noncanonical Wnt pathway, CaM-bound CaMKII interfere with the canonical
  β-catenin/TCF/LEF signaling. CaM, Ca2+-calmodulin; EGFR, epidermal growth factor
  receptor; ERK, extracellular signal-regulated kinase; MAPK, Raf/MEK/ERK; MEK, MAPK
  kinase; mTORC1, mTOR complex 1; mTORC2, mTOR complex 2; PDK, phosphoinositide-dependent
  protein kinase; PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol
  3,4,5-bisphosphate; PTEN, phosphatase and tensin homolog; RTK, receptor tyrosine
  kinase; TCF/LEF, T-cell factor/lymphoid enhancing factor.
papertitle: 'Review: Precision medicine and driver mutations: Computational methods,
  functional assays and conformational principles for interpreting cancer drivers.'
reftext: Ruth Nussinov, et al. PLoS Comput Biol. 2019 Mar;15(3):e1006658.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9626544
figid_alias: PMC6438456__F10
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6438456__F10
ndex: 48daa72b-ded9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6438456__pcbi.1006658.g010.html
  '@type': Dataset
  description: Representatives shown for the MAPK, PI3K/Akt, and Wnt pathways. In
    the MAPK pathway, Ras gets activated in the presence of the EGFR signal and forms
    nanoclusters that promote Raf dimerization. Autophosphorylated, active Raf dimer
    phosphorylates and activatesMEK 1/2, and subsequently phosphorylates and activates
    ERK 1/2, leading to cell proliferation. In the PI3K/Akt pathway, both Ras and
    RTK activate PI3K, recruiting it to the plasma membrane, where PI3K phosphorylates
    PIP2 to produce PIP3. The tumor suppressor PTEN can reverse the PIP3 production.
    PIP3 recruits both PDK and Akt to the plasma membrane, where PDK and mTORC2 activate
    Akt, and active Akt phosphorylates the mTORC1, leading to cell growth. The canonical
    Wnt pathway involves an accumulation of β-catenin in the cytoplasm and translocates
    β-catenin to the nucleus where it binds to TCF/LEF transcription factors. β-catenin
    upregulates c-Myc. In the noncanonical Wnt pathway, CaM-bound CaMKII interfere
    with the canonical β-catenin/TCF/LEF signaling. CaM, Ca2+-calmodulin; EGFR, epidermal
    growth factor receptor; ERK, extracellular signal-regulated kinase; MAPK, Raf/MEK/ERK;
    MEK, MAPK kinase; mTORC1, mTOR complex 1; mTORC2, mTOR complex 2; PDK, phosphoinositide-dependent
    protein kinase; PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol
    3,4,5-bisphosphate; PTEN, phosphatase and tensin homolog; RTK, receptor tyrosine
    kinase; TCF/LEF, T-cell factor/lymphoid enhancing factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - fz
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pdk
  - Pdk1
  - Akt
  - dsh
  - Egfr
  - Axn
  - Pten
  - Raf
  - Apc
  - Apc2
  - Fs(3)Apc
  - sgg
  - gskt
  - rictor
  - raptor
  - Mtor
  - Tor
  - arm
  - MKP-4
  - p38b
  - rl
  - Erk7
  - Dsor1
  - S6k
  - Crtc
  - cal
  - Cam
  - CaMKII
  - Myc
  - pan
  - Jra
  - ra
  - pk
  - ca
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - AKT1
  - AKT2
  - AKT3
  - ADAR
  - DVL1P1
  - EGFR
  - AXIN1
  - AXIN2
  - PTEN
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - APC
  - PROC
  - GSK3B
  - RICTOR
  - MTOR
  - MLST8
  - CTNNB1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - MAP2K1
  - MAP2K2
  - RPS6KB1
  - RPS6KB2
  - MAPKAP1
  - RPTOR
  - FBLIM1
  - GOPC
  - CA1
  - CALM1
  - CALM2
  - CALM3
  - KRIT1
  - CAMKMT
  - ELK1
  - KCNH4
  - KCNH8
  - MYC
  - HNF4A
  - CAMK2G
  - JUN
  - CAMK2B
  - CAMK2A
  - CAMK2D
  - Ca
  - SINI
---
